Related Experiment Video
Updated: Aug 25, 2025

Digital Home-Monitoring of Patients after Kidney Transplantation: The MACCS Platform
Published on: April 12, 2021
The Risks of Using Trimethoprim/Sulfamethoxazole in Patients with Renal and Cardiac Compromise
Arlene F Hoffman1, Tzu Lu Lin2
1*Private practice, San Francisco, CA; Department of Medicine and Surgery, Western University of Health Sciences College of Podiatric Medicine, Pomona, CA.
Abstract:
The purpose of this article is to familiarize physicians with the risks of prescribing trimethoprim/sulfamethoxazole (TMP/SMX) for patients who have kidney or cardiac pathology, have hyperkalemia, or take other interacting medications. Although TMP/SMX is a drug that is frequently used to treat skin and soft-tissue infections of the leg and foot, particularly if methicillin-resistant Staphylococcus aureus is identified, it is not an innocuous antibiotic. Literature documenting the many adverse effects of TMP/SMX is reviewed. A case history is presented illustrating the association of TMP/SMX with the development of a life-threatening situation. Ways of avoiding these adverse events are discussed, and the use of safer antibiotics is recommended.
Insights
Trimethoprim/sulfamethoxazole (TMP/SMX) can cause serious adverse events, particularly in patients with kidney or cardiac issues, hyperkalemia, or those on interacting medications. Physicians should carefully weigh risks and consider safer antibiotic alternatives.
Area of Science:
- Pharmacology
- Infectious Diseases
- Nephrology
Background:
- Trimethoprim/sulfamethoxazole (TMP/SMX) is commonly prescribed for leg and foot skin infections, including those caused by methicillin-resistant Staphylococcus aureus.
- Despite its frequent use, TMP/SMX carries significant risks that necessitate careful consideration in patient selection.
Purpose of the Study:
- To inform physicians about the potential dangers of prescribing TMP/SMX.
- To highlight specific patient populations and medication interactions that increase adverse event risk.
Main Methods:
- Review of existing literature on TMP/SMX adverse effects.
- Presentation of a case study demonstrating a life-threatening complication associated with TMP/SMX use.
Main Results:
- TMP/SMX is associated with numerous adverse effects, including potentially life-threatening situations.
- Specific patient comorbidities (kidney/cardiac pathology, hyperkalemia) and drug interactions elevate risk.
Conclusions:
- Physicians must be aware of TMP/SMX risks, especially in vulnerable patients.
- Strategies to mitigate adverse events should be implemented.
- Alternative, safer antibiotics are recommended when appropriate.
Related Concept Videos
Renal Failure: Dose Adjustments
Reduced renal clearance and elimination rate are common outcomes of renal impairment. These alterations lead to a prolonged elimination half-life and an altered apparent volume of distribution for drugs. As a result, dosage adjustments are typically necessary to maintain optimal drug levels in the body.
However, dosage adjustments...
Heart Failure Drugs: Diuretics
Heart Failure Drugs: Inhibitors of Renin-Angiotensin System
Acute Kidney Injury IV: Diagnostic Studies and Prevention
Combined Effects of Drugs: Synergism
Such synergistic combinations...
Factors Affecting Drug Response: Overview

